Loading stock…

Bruker Corporation (BRKR) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Bruker Corporation

BRKRMarket cap $9.22BPrice $60.5

Country🇺🇸United States

SectorHealthcare

IndustryLife Sciences

Builds the scientific instruments that decode molecules, from mass spectrometers to MRI machines used in drug discovery and diagnostics. Scientists worldwide rely on its tech to see what's invisible to the naked eye, atom by atom.

In Bastion Portfolios?

52W Return+64%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+11%7

Revenue Forecast

Rev CAGR (1y)+3%4

Rev CAGR (3y)+5%4

Rev CAGR (5y)+5%5

Earnings Forecast

EPS Growth Y+1+179%10

EPS Growth Y+2+14%7

EPS Growth Y+3+16%8

Quality

Margins

EBIT Margin9%4

Net Income Margin-2%2

Free Cash Flow Margin3%3

Debt

Net Debt/EBITDA2.83

Efficiency

ROE-5%2

ROA-1%2

Earnings Stability77

GEAR+VERY WEAK10

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)282

P/E Ratio (Forward 3y)223

P/BV3.94

EV Multiples

EV/EBITDA Fwd183

EV/EBIT Fwd214

Yield

Free Cash Flow Yield1.0%3

Dividend Yield0.3%1

Momentum

Short term

1 month return+4%9

3 month return+4%7

YTD return+29%8

Mid term

Price vs 52wHigh90%8

1 year return+76%10

Long term

3 year return-2%3

5 year return-21%2

Risk Shield

Price Risk

Beta1.23

Volatility57%2

Free Cash Flow

Free Cash Flow Margin3%3

Free Cash Flow Yield1.0%3

Quality

ROCE6%4

Earnings Stability77

Net Debt/EBITDA2.83

02Growth

Is it actually growing, and how fast?

BRKRBruker

Revenue FY25$3.4B

GROWTH RATING↗

AVERAGE46 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+3%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+179%10

EPS growth, FY27E+14%7

EPS growth, FY28E+16%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 46% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 11%/yr over the last 3 years; forecasts see it cooling to 5%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG67 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+4%9

3-month return+4%7

YTD return+29%8

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+76%10

3-year return-2%3

5-year return-21%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 76% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+4%), over three months (+4%) and so far this year (+29%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-2.5% over three years and -21% over five), behind 70% of the market.

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Bruker Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

BRKRBruker

Revenue FY25$3.4B

GROWTH RATING↗

AVERAGE46 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+3%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+179%10

EPS growth, FY27E+14%7

EPS growth, FY28E+16%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 46% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 11%/yr over the last 3 years; forecasts see it cooling to 5%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG67 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+4%9

3-month return+4%7

YTD return+29%8

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+76%10

3-year return-2%3

5-year return-21%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 76% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+4%), over three months (+4%) and so far this year (+29%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-2.5% over three years and -21% over five), behind 70% of the market.

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Bruker Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community